Higher Risks of Toxicity and Incomplete Recovery in 13- to 17-Year-Old Females after Marrow Donation: RDSafe Peds Results

This publication has 25 references indexed in Scilit:

• High prevalence of daily and multi-site pain – a cross-sectional population-based study among 3000 Danish adolescents
  BMC Pediatrics, 2013
• Acute toxicities of unrelated bone marrow versus peripheral blood stem cell donation: results of a prospective trial from the National Marrow Donor Program
  Blood, 2013
• Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study
  Blood, 2012
• Children as Hematopoietic Stem Cell Donors
  Pediatrics, 2010
• Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program
  Blood, 2009
• Recovery and Safety Profiles of Marrow and PBSC Donors: Experience of the National Marrow Donor Program
  Transplantation and Cellular Therapy, 2008
• Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry
  Haematologica, 2008
• A prospective study of G-CSF–primed bone marrow as a stem-cell source for allogeneic bone marrow transplantation in children: a Pediatric Blood and Marrow Transplant Consortium (PBMTC) study
  Blood, 2007
• Weighing the risks of G‐CSF administration, leukopheresis, and standard marrow harvest: Ethical and safety considerations for normal pediatric hematopoietic cell donors
  Pediatric Blood & Cancer, 2006
• Safety and efficacy of allogeneic PBSC collection in normal pediatric donors: The Pediatric Blood and Marrow Transplant Consortium Experience (PBMTC) 1996–2003
  Bone Marrow Transplantation, 2004